Redwood Financial Network’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$314K Buy
1,444
+3
+0.2% +$665 0.21% 132
2025
Q4
$329K Sell
1,441
-93
-6% -$21.2K 0.21% 128
2025
Q3
$355K Sell
1,534
-115
-7% -$23.4K 0.22% 123
2025
Q2
$306K Buy
1,649
+161
+11% +$29.9K 0.21% 124
2025
Q1
$312K Buy
1,488
+6
+0.4% +$1.17K 0.24% 114
2024
Q4
$263K Sell
1,482
-82
-5% -$15.1K 0.2% 124
2024
Q3
$309K Sell
1,564
-105
-6% -$19.6K 0.24% 108
2024
Q2
$286K Buy
1,669
+286
+21% +$47.4K 0.24% 116
2024
Q1
$252K Buy
1,383
+2
+0.1% +$345 0.22% 120
2023
Q4
$214K Buy
1,381
+3
+0.2% +$437 0.21% 129
2023
Q3
$205K Sell
1,378
-826
-37% -$121K 0.22% 128
2023
Q2
$297K Buy
2,204
+6
+0.3% +$880 0.28% 111
2023
Q1
$350K Sell
2,198
-191
-8% -$29.2K 0.36% 95
2022
Q4
$386K Buy
2,389
+256
+12% +$39.3K 0.44% 74
2022
Q3
$286K Buy
2,133
+5
+0.2% +$717 0.33% 97
2022
Q2
$326K Sell
2,128
-112
-5% -$17.1K 0.36% 93
2022
Q1
$363K Buy
+2,240
New +$325K 0.34% 95

Other funds holding ABBV

Redwood Financial Network's ABBV Position: Q1 2026 in Review

Redwood Financial Network increased its AbbVie (ABBV) stake by 0.21% in Q1 2026, buying an estimated $665 and bringing the position to 1,444 shares worth $314K. The position accounts for 0.21% of the portfolio, ranked #132.

Redwood Financial Network first reported a position in ABBV in Q1 2022 and has held it in 17 quarters since. The position peaked at $386K in Q4 2022. 4,076 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Redwood Financial Network held 1,444 shares of AbbVie worth $314K as of Q1 2026.
  • Redwood Financial Network bought 3 AbbVie shares in Q1 2026, an estimated $665.
  • AbbVie made up 0.21% of Redwood Financial Network's portfolio in Q1 2026, its #132 holding.
  • Redwood Financial Network first reported a position in AbbVie in Q1 2022 and has held it in 17 quarters since.
  • Redwood Financial Network's AbbVie position peaked at $386K in Q4 2022.
  • 4,076 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Redwood Financial Network's 13F filing for Q1 2026, filed 14 May 2026.